Back

6 years of ARNI use in Israel - effectiveness analysis in real world data

31 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure pharmacotherapy updates Angiotensin-Renin-Bradykinin System ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Zaza Iakobishvili

Holon Medical Center, Tel Aviv (Israel)

3 More presentations in this session

Presentation thumbnail
Safety and efficacy of potassium binders on hyperkalemia: a novel systematic review and meta-analysis of randomized controlled trials
Ms M. Werlang (Rio Do Sul, BR)
Abstract Slides Video
Presentation thumbnail
Gender differences in mortality benefit of raas inhibitors in heart failure: a retrospective cohort study
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach
Doctor M. Patricio (Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

31 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy
thumbnail
Congress Presentation
Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources